OUR EXPERIENCE WITH TERIPARATIDE (FORSTEO) IN PATIENTS WITH SEVERE OSTEOPOROSIS

被引：0
|
作者：
Popova, V. P. [1 ]
Popova, M. P. Gebeva [1 ]
Vazhev, Z. V. [2 ]
Ronchev, Y. R. [3 ]
Kraev, K. K. [1 ]
Batalov, A. B. [1 ]
机构：
[1] Med Univ Plovdiv, Med Fac, Dept Rheumatol, Plovdiv, Bulgaria
[2] Med Univ Plovdiv, Med Fac, Dept Cardiac Surg, Plovdiv, Bulgaria
[3] Med Univ Plovdiv, Med Fac, Dept Inubil, Plovdiv, Bulgaria
来源：
OSTEOPOROSIS INTERNATIONAL | 2021年 / 32卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P399
引用
收藏
页码：S231 / S232
页数：2
相关论文
共 50 条
  • [41] Teriparatide (Forsteo((R))): Osteoanabolics: Current Therapeutic Aspects
    Messner, Mag. Birgit
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (01): : 65 - 66
  • [42] PRELIMINARY EXPERIENCE OF TREATMENT WITH TERIPARATIDE OF POST-OLT SEVERE OSTEOPOROSIS UNRESPONSIVE TO STANDARD THERAPY
    Valente, G.
    Italiano, G.
    Rinaldi, L.
    Sgambato, M.
    Piai, G.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E68 - E68
  • [43] Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis
    Lasco, A.
    Catalano, A.
    Morabito, N.
    Gaudio, A.
    Basile, G.
    Trifiletti, A.
    Atteritano, M.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (01) : 299 - 303
  • [44] Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis
    A. Lasco
    A. Catalano
    N. Morabito
    A. Gaudio
    G. Basile
    A. Trifiletti
    M. Atteritano
    Osteoporosis International, 2011, 22 : 299 - 303
  • [45] Dual Therapy with Teriparatide and Denosumab in Severe Osteoporosis.
    Claffey, Paul
    Broderick, Aoife
    O'Toole, Ronan
    Mahon, James
    McCarroll, Kevin
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S268 - S268
  • [46] TERIPARATIDE: THE FIRST THERAPEUTIC OPTION FOR SEVERE POSTMENOPAUSAL OSTEOPOROSIS
    Naumescu, S.
    Hritiuc, A.
    Moldovan, C.
    Carsote, M.
    Georgescu, C. E.
    Valea, A.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S751 - S751
  • [47] Indications to teriparatide treatment in patients with osteoporosis
    Rizzoli, Rene
    Kraenzlin, Marius
    Krieg, Marc-Antoine
    Mellinghoff, Hans-Ulrich
    Lamy, Olivier
    Lippuner, Kurt
    SWISS MEDICAL WEEKLY, 2011, 141
  • [48] Efficacy of raloxifene and teriparatide in patients with osteoporosis
    Marie Lofthouse
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 (4): : 182 - 183
  • [49] Compliance, acceptance, and safety of teriparatide injection over 18 months in patients with severe osteoporosis
    Adachi, J. D.
    Hanley, D. A.
    Lorraine, J. K.
    Tam, F.
    Boudreau, T.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S236 - S236
  • [50] OUR EXPERIENCE AND ANALYSIS OF QUALITY OF LIFE AND CHANGES IN BMD IN PATIENTS TREATED WITH TERIPARATIDE
    Popova, V.
    Geneva-Popova, M.
    Kraev, K.
    Kartev, S.
    Popov, I.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S140 - S141
12345